Equity | Note 8 – Equity A. Stock option plans During the nine months ended September 30, 2016 and September 30, 2015, 270,000 and 135,000 options were granted, respectively. The vesting period for the options ranges from one year to four years. The exercise prices for the options range from $0.44 to $1.68. Those options expire up to five years after the date of the grant. Any options which are forfeited or cancelled before expiration become available for future grants under the Company’s option plan. The fair value of each option granted to employees and non-employees during the nine months ended September 30, 2016 and September 30, 2015, for which the exercise price was greater than par value, was estimated on the date of grant, using the Black-Scholes model and the following assumptions: 1. Dividend yield of zero percent for all periods. 2. Risk-free interest rate of 1.03% and 1.21% for grants during the nine months ended September 30, 2016 and September 30, 2015, respectively, based on U.S. Treasury yield curve in effect at the time of grant. 3. Estimated expected lives of 3.56 and 3.5 years for grants during the nine months ended September 30, 2016 and September 30, 2015, respectively, using the simplified method. 4. Expected average volatility of 72% and 69% for grants during the nine months ended September 30, 2016 and September 30, 2015, respectively, which represent a weighted average standard deviation rate for the price of the Company's Ordinary Shares on the NASDAQ Global Market and NASDAQ Capital Market. The Company’s options activity (including options to non-employees) during the nine months ended September 30, 2016 and options outstanding and options exercisable as of December 31, 2015 and September 30, 2016, are summarized in the following table: Number of Weighted options average exercise outstanding price per share Outstanding – December 31, 2015 1,601,379 $ 1.71 Options granted 270,000 0.76 Options expired or forfeited (461,448 ) 2.07 Options exercised (54,260 ) 0.68 Outstanding – September 30, 2016 1,355,671 1.44 Exercisable as of: December 31, 2015 799,473 $ 1.85 September 30, 2016 701,018 $ 1.78 The weighted average fair value of options granted during the nine months ended September 30, 2016 and during the nine months ended September 30, 2015 is $0.41 and $0.82, respectively, per option. The aggregate intrinsic value of outstanding options as of September 30, 2016 and December 31, 2015 is approximately $174 and $8, respectively. The aggregate intrinsic value of exercisable options as of September 30, 2016 and December 31, 2015 is approximately $26 and $8, respectively. The following table summarizes information about options outstanding and exercisable (including options to non-employees) as of September 30, 2016: Options outstanding Options Exercisable Number Weighted Number Weighted outstanding average Weighted Outstanding average Weighted as of remaining Average As of remaining Average Range of September 30, contractual Exercise September 30, contractual Exercise exercise price 2016 life (years) Price 2016 life (years) Price $ 0.44-0.90 630,000 4.05 $ 0.76 111,667 3.08 $ 0.81 1.08-1.20 133,000 0.45 1.09 133,000 0.45 1.09 1.46 50,000 1.80 1.46 50,000 1.80 1.46 1.67-1.76 65,000 2.40 1.69 35,000 1.66 1.70 2.32-2.36 437,671 2.43 2.34 351,351 2.40 2.34 $ 3.03 40,000 2.98 $ 3.03 20,000 2.98 $ 3.03 1,355,671 2.98 701,018 2.08 As of September 30, 2016, there was approximately $270 of total unrecognized compensation cost related to non-vested stock-based compensation arrangements. That cost is expected to be recognized over a weighted-average period of approximately 1 year. During the nine months ended September 30, 2016 and September 30, 2015, the Company recorded stock-based compensation expenses in the amount of $174 and $369, respectively, in accordance with ASC 718 “Compensation-Stock Compensation.” B. Warrants During the nine months ended September 30, 2016, 281,369 warrants expired and 36,142 warrants were converted to ordinary shares. As of September 30, 2016 there are no remaining outstanding warrants. C. During the nine months ended September 30, 2016, the Company issued 15,000 ordinary shares to one of its consultants. The expenses that are recognized due to this issuance are immaterial and the issuance is presented within ‘stock based compensation’ in the statement of changes in equity for the nine months ended September 30, 2016. |